You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Mawi's iSWAB line of biospecimen collection devices include its flagship iSWAB-DNA for the collection of long-fragment double-stranded DNA in buccal cells.
Proteintech said that the combined companies will better address growing challenges in single-cell analysis, super-resolution imaging, and multiplex assays.
The synbio company offers scale and lower costs in "massive" end markets, SVB Leerink analysts said, and could soon command an even more attractive valuation.
Under the deal, the companies will offer NRGene software for SNP set creation with AgriPlex's genotyping platform and data analysis software.
For the three months ended June 30, the firm reported revenues of $5.4 million, down from $6.3 million in the year-ago quarter and missing the consensus Wall Street estimate of $5.9 million.
The German diagnostics firm expects more than €80 million in 2020 revenues, driven by its recovering core business and its COVID-19 testing business.
Researchers uncovered rare, damaging mutations in genes involved in early brain development among 22 percent of 381 sporadic congenital hydrocephalus cases.
PathogenDx has developed a technology that detects pathogen DNA found on surfaces with applications in agriculture and clinical lab testing.
The agency issued a new draft decision memo, outlining various criteria it intends to apply when determining coverage for current and future blood-based CRC screening tests.
The US Department of Health and Human Services (HHS) said that it would use Fluidigm's saliva-based molecular SARS-CoV-2 test as part of a federal surge testing program.
The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.
The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.
Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.
In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.